- Title
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
- Creators - without role
- Yves Dauvilliers - Université de Montpellier, Institut des Neurosciences de Montpellier - INMIsabelle Arnulf - Pitié-Salpêtrière HospitalNancy Foldvary-Schaefer - Cleveland Clinic Lerner College of MedicineAnne Marie Morse - Geisinger Medical CenterKarel Šonka - Charles UniversityMichael Thorpy - Albert Einstein College of MedicineEmmanuel Mignot - Stanford UniversityPatricia Chandler - Jazz PharmaceuticalsRupa Parvataneni - Jazz PharmaceuticalsJed Black - Jazz PharmaceuticalsAmanda Sterkel - Jazz PharmaceuticalsDan Chen - Jazz PharmaceuticalsFranck Skobieranda - Jazz PharmaceuticalsRichard Bogan - University of South Carolina
- Publication Details
- The Lancet Neurology, Vol.21(1), pp.53-65
- Identifiers
- 9939585109311
- Academic Unit
- Institut des Neurosciences de Montpellier - INM
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-04965869
Journal article
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
The Lancet Neurology, Vol.21(1), pp.53-65
01/2022
Metrics
1 Record Views